Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference
Evolus (NASDAQ: EOLS), a performance beauty company, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. Sandra Beaver, CFO of Evolus, will present at the event on Tuesday, August 13, 2024, from 12:30 – 12:55 PM ET.
The presentation will take the form of a fireside chat, which will be accessible to investors via a webcast on the Investor Relations page of the Evolus website. For those unable to attend live, a replay of the webcast will be available for 90 days following the presentation, providing ample opportunity for investors to gain insights into the company's growth strategies and performance.
Evolus (NASDAQ: EOLS), un'azienda operante nel settore della bellezza performante, ha annunciato la sua partecipazione alla 44ª Conferenza Annuale sulla Crescita di Canaccord Genuity. Sandra Beaver, CFO di Evolus, presenterà durante l'evento martedì 13 agosto 2024, dalle 12:30 alle 12:55 PM ET.
La presentazione avrà la forma di una chiacchierata informale, accessibile agli investitori tramite una trasmissione in diretta sulla pagina delle Relazioni con gli Investitori del sito web di Evolus. Per coloro che non possono partecipare dal vivo, sarà disponibile una registrazione della trasmissione per 90 giorni dopo la presentazione, offrendo così ampie opportunità agli investitori per acquisire informazioni sulle strategie di crescita e sulle performance dell'azienda.
Evolus (NASDAQ: EOLS), una empresa de belleza de alto rendimiento, ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity. Sandra Beaver, CFO de Evolus, presentará en el evento el martes 13 de agosto de 2024, de 12:30 a 12:55 PM ET.
La presentación tomará la forma de una charla informal, que será accesible para los inversores a través de una transmisión web en la Página de Relaciones con Inversores del sitio web de Evolus. Para aquellos que no puedan asistir en vivo, habrá una reposición de la transmisión disponible por 90 días después de la presentación, brindando amplias oportunidades para que los inversores obtengan información sobre las estrategias de crecimiento y el rendimiento de la empresa.
에볼루스 (NASDAQ: EOLS), 성과 중심의 뷰티 기업이 캐너코드 제뉴이티 제44회 연례 성장 컨퍼런스에 참가할 것을 발표했습니다. 산드라 비버 에볼루스 CFO가 2024년 8월 13일 화요일 오후 12:30 - 12:55 ET에 이 행사에서 발표할 예정입니다.
발표는 대화 형식으로 진행되며, 에볼루스 웹사이트의 투자자 관계 페이지를 통해 투자자들이 웹캐스트를 통해 접근할 수 있습니다. 생중계에 참석할 수 없는 분들을 위해, 발표 후 90일 동안 웹캐스트 재방송이 제공되어 투자자들이 회사의 성장 전략과 성과에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
Evolus (NASDAQ: EOLS), une entreprise de beauté performante, a annoncé sa participation à la 44ème Conférence Annuelle de Croissance de Canaccord Genuity. Sandra Beaver, CFO d'Evolus, présentera lors de l'événement le mardi 13 août 2024, de 12h30 à 12h55 ET.
La présentation prendra la forme d'une discussion informelle, qui sera accessible aux investisseurs via un webinaire sur la page des Relations Investisseurs du site Web d'Evolus. Pour ceux qui ne peuvent pas assister en direct, un replay du webinaire sera disponible pendant 90 jours après la présentation, offrant ainsi aux investisseurs une grande opportunité d'obtenir des informations sur les stratégies de croissance et la performance de l'entreprise.
Evolus (NASDAQ: EOLS), ein Unternehmen für leistungsstarke Schönheit, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity bekannt gegeben. Sandra Beaver, CFO von Evolus, wird am Dienstag, den 13. August 2024, von 12:30 bis 12:55 Uhr ET auf der Veranstaltung präsentieren.
Die Präsentation erfolgt in Form eines Kamin-Gesprächs, das für Investoren über ein Webcast auf der Investorenrelations-Seite der Evolus-Website zugänglich sein wird. Für diejenigen, die nicht live teilnehmen können, wird eine Aufzeichnung des Webcasts für 90 Tage nach der Präsentation verfügbar sein, was den Investoren ausreichend Gelegenheit bietet, Einblicke in die Wachstumsstrategien und die Leistung des Unternehmens zu erhalten.
- None.
- None.
Event: The Canaccord Genuity 44th Annual Growth Conference
Date: Tuesday, August 13, 2024
Time: 12:30 – 12:55 PM ET
The fireside chat can be accessed on the Investor Relations page of the Evolus website here. A replay of the webcast will be available for 90 days following the presentation.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive
Jeuveau® and Nuceiva®, are registered trademarks and Evolysse™ is a trademark of Evolus, Inc.
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
Estyme® is a trademark of Symatese Aesthetics S.A.S.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240730687924/en/
Investors:
Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications
Phone: (248) 202-9267
Email: ir@evolus.com
Media:
Email: media@evolus.com
Source: Evolus
FAQ
When is Evolus (EOLS) presenting at the Canaccord Genuity Growth Conference?
Who will be representing Evolus (EOLS) at the Canaccord Genuity conference?
How can investors access Evolus's (EOLS) presentation at the Canaccord Genuity conference?
How long will the replay of Evolus's (EOLS) presentation be available?
